iRhythm Technologies logo
IRTCiRhythm Technologies
Trade IRTC now
iRhythm Technologies primary media

About iRhythm Technologies

iRhythm Technologies (NASDAQ:IRTC) specializes in healthcare solutions, focusing on the advancement and proliferation of cardiac monitoring technologies. It is solely listed on the NASDAQ stock market under the ticker symbol IRTC. The company is keenly centered around innovating in the field of digital health, striving to enhance patient outcomes and streamline cardiac care through its state-of-the-art monitoring devices and data analysis tools. iRhythm aims to transform the way cardiac arrhythmias are clinically diagnosed by making its technology accessible and easy to use for both healthcare providers and patients. Through its dedicated research and development efforts, iRhythm aspires to lead in the discovery of new methods and solutions that promote heart health and well-being globally.

What is IRTC known for?

Snapshot

Public US
Ownership
2008
Year founded
1487
Employees
San Francisco, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
San Francisco, US

Produtos e/ou serviços de iRhythm Technologies

  • Zio XT is a wearable cardiac monitor that allows for long-term continuous heart rhythm monitoring, providing detailed reports for diagnosis.
  • Zio AT is an auto-trigger looping monitor capturing abnormal heart rhythms, offered for shorter monitoring periods.
  • Zio Service includes the proprietary algorithms and expert analysis by certified technologists, offering in-depth insights into the collected data.
  • myZio is a patient-centric app designed to improve the patient experience by facilitating better communication and engagement during the monitoring period.
  • Zio Watch, a smartwatch-based solution, offers continuous ECG monitoring aimed at detecting atrial fibrillation and other heart rhythm irregularities.
  • Research and Development focused on advancing cardiac monitoring technology, aiming to enhance accuracy, patient compliance, and overall diagnostic yield.

equipe executiva do iRhythm Technologies

  • Mr. Quentin S. BlackfordPresident, CEO & Director
  • Mr. Daniel G. WilsonCFO & Principal Financial Officer
  • Dr. Minang P. Turakhia M.D., M.S.Chief Medical & Scientific Officer and Executive VP of Advanced Technologies
  • Mr. Patrick Michael Murphy J.D.Chief Business & Legal Officer
  • Mr. Chad M. PattersonChief Commercial and Product Officer
  • Mr. Mervin SmithExecutive Vice President of Business Operations
  • Mr. Marc RosenbaumSenior VP of Finance & Chief Accounting Officer
  • Mr. Brian LawrenceExecutive VP & CTO
  • Mr. Sean Clinton FreemanExecutive Vice President of Strategy & Corporate Development
  • Ms. Sumi ShrishrimalExecutive VP & Chief Risk Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.